[HTML][HTML] BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

…, S Baumann, AJ Mahiny, G Boros, J Reinholz… - Nature, 2021 - nature.com
BNT162b2, a nucleoside-modified mRNA formulated in lipid nanoparticles that encodes the
SARS-CoV-2 spike glycoprotein (S) stabilized in its prefusion conformation, has …

Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera

…, BG Lui, AK Wallisch, M Bacher, J Mühl, J Reinholz… - Science, 2022 - science.org
The globally circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variant of concern Omicron (B.1.1.529) has a large number of mutations, especially in the spike …

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans

…, S Baumann, AJ Mahiny, G Boros, J Reinholz… - MedRxiv, 2020 - medrxiv.org
BNT162b2, a lipid nanoparticle (LNP) formulated nucleoside-modified messenger RNA (mRNA)
encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike …

Protein machineries defining pathways of nanocarrier exocytosis and transcytosis

J Reinholz, C Diesler, S Schöttler, M Kokkinopoulou… - Acta biomaterialia, 2018 - Elsevier
The transport of nanocarriers through barriers like the gut in a living organism involves the
transcytosis of these nanocarriers through the cell layer dividing two compartments. …

Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona

…, D Estupiñán, M Kokkinopoulou, J Reinholz… - Nature …, 2018 - nature.com
To promote drug delivery to exact sites and cell types, the surface of nanocarriers is functionalized
with targeting antibodies or ligands, typically coupled by covalent chemistry. Once the …

The challenges of oral drug delivery via nanocarriers

J Reinholz, K Landfester, V Mailänder - Drug delivery, 2018 - Taylor & Francis
The oral application of pharmaceuticals is unarguably the most convenient method of
application. Especially for protein- or peptide-based drugs, however, the effectiveness is …

Exposure to BA. 4/5 S protein drives neutralization of Omicron BA. 1, BA. 2, BA. 2.12. 1, and BA. 4/5 in vaccine-experienced humans and mice

…, J Mottl, T Ziegenhals, S Fesser, J Reinholz… - Science …, 2022 - science.org
The SARS-CoV-2 Omicron variant and its sublineages show pronounced viral escape from
neutralizing antibodies elicited by vaccination or prior SARS-CoV-2 variant infection owing to …

Submicrometer-sized roughness suppresses bacteria adhesion

…, A Kaltbeitzel, P Baumli, J Reinholz… - … applied materials & …, 2020 - ACS Publications
Biofilm formation is most commonly combatted with antibiotics or biocides. However, proven
toxicity and increasing resistance of bacteria increase the need for alternative strategies to …

Efficient nanofibrous membranes for antibacterial wound dressing and UV protection

S Jiang, BC Ma, J Reinholz, Q Li, J Wang… - … applied materials & …, 2016 - ACS Publications
Materials with a hierarchical structure often demonstrate superior properties with combined
and even synergistic effects of multiple functions. Herein, we report the design of a new class …

[HTML][HTML] Ribozyme assays to quantify the capping efficiency of in vitro-transcribed mRNA

…, J Reichert, M Buff, M Baiersdörfer, J Reinholz… - Pharmaceutics, 2022 - mdpi.com
The presence of the cap structure on the 5′-end of in vitro-transcribed (IVT) mRNA determines
its translation and stability, underpinning its use in therapeutics. Both enzymatic and co-…